ArticleArthritis research & therapy2013

Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop.

Ayako Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.